History of uterine transplantation
Uterine transplantation represents one of the most innovative and complex frontiers of transplant medicine. Born as a dream for women with absolute uterine infertility (AUFI), this procedure has rapidly evolved its techniques and methodologies, transforming itself from a pioneering experiment to an increasingly consolidated clinical reality. In recent years, Texas has positioned itself as one of the most advanced centers in the world for uterine transplantation, perfecting the procedure from both a surgical and management point of view. This article explores the history, challenges, progress and future prospects of uterine transplantation, with a particular focus on developments in Texas. The idea of ​​a uterine transplant as a solution to uterine infertility dates back to the 1960s, but it was only in 2000 that the concept began to take shape through preclinical research.
The first documented uterus transplant in humans was performed in Saudi Arabia in 2000, but the uterus had to be removed after only 99 days due to thrombotic complications. This initial failure highlighted the need for further research and development. In the following decades, numerous animal experiments, particularly in mouse and porcine models, helped to refine surgical techniques and better understand the immunological and vascular requirements of a uterus transplant. The first successful uterus transplant, resulting in the birth of a healthy baby, was performed in Sweden in 2014. This transplant represented a historic breakthrough, demonstrating that uterus transplantation could not only be technically feasible, but also lead to a full-term pregnancy and birth.
Texas programs development
Texas, particularly Baylor University Medical Center in Dallas, has become a center of excellence for uterine transplantation, thanks to the commitment of a multidisciplinary team that has worked to improve every aspect of the procedure. Over the years, Baylor surgeons have perfected the microsurgical techniques used to connect the blood vessels of the donor uterus with those of the recipient, reducing the risk of thrombosis and improving the perfusion of the transplanted organ. Another crucial aspect perfected in Texas was the management of immunosuppressive therapy, necessary to prevent rejection of the transplanted uterus. Researchers have developed customized protocols to minimize long-term side effects while protecting the organ’s function. The Texas experience has led to a greater understanding of the ideal characteristics of donors and recipients, helping to improve transplant success rates.
Donor and recipient characteristics
Donor profile
Donor selection is critical to the success of uterine transplantation. In Texas, stringent criteria have been developed to ensure that donors are in good health and that the donated uterus has the best chance of functioning properly after transplantation. Although living donor transplantation was initially preferred because of the ability to perform detailed preoperative evaluations, deceased donor transplants are becoming more common. This is due to increased organ availability and reduced risk to the donor. Living donors must be under 40 years of age, have completed their reproductive cycle, and have no uterine or systemic disease that could compromise the function of the transplanted uterus. Deceased donors must have been in good general health prior to death, and the uterus must be free of structural or functional abnormalities.
Recipient Profile
Recipients are typically women with absolute uterine infertility, a condition in which pregnancy is not possible due to congenital absence of the uterus (such as in Mayer-Rokitansky-Küster-Hauser syndrome) or loss of the uterus for medical reasons. Recipients must be in good general health, between the ages of 20 and 40, and must have no medical contraindications to surgery or long-term immunosuppressive therapy. They must also be able to carry a low-risk pregnancy to term and accept the need for a scheduled cesarean section. In addition to medical evaluations, recipients must undergo a thorough psychological evaluation to ensure they are mentally and emotionally prepared to handle the complexities of transplantation and subsequent pregnancy.
Surgical procedure and postoperative management
The Transplant Process
Uterine transplantation is a complex surgical procedure that requires high microsurgical precision. The procedure is performed in several stages, from removal of the uterus from the donor to implantation in the recipient.
- Uterine removal: In the case of a living donor, the uterine removal is performed using minimally invasive surgical techniques, when possible, to reduce trauma and speed recovery. In the case of deceased donors, the uterus is removed along with the major blood vessels and prepared for transplantation.
- Recipient implantation: Implantation of the uterus into the recipient requires precise connection of the blood vessels and uterine ligaments to the recipient’s circulation. Vascular patency and anatomical integrity are critical to the success of the transplant.
- Functional verification: After implantation, uterine perfusion is verified and the recipient’s immunological response is monitored to prevent acute rejection.
Postoperative Care
Postoperative care is essential to ensure the long-term success of the transplant and the health of the recipient and any fetus.
- Immunosuppressive Therapy: The recipient must follow rigorous immunosuppressive therapy to prevent rejection of the transplanted uterus. The protocols used in Texas have been refined to minimize the risk of infections and other long-term side effects.
- Pregnancy Monitoring: Once the recipient is stabilized and the uterus is functioning properly, ovarian stimulation and embryo implantation can begin. The pregnancy is carefully monitored throughout, with particular attention to placental perfusion and fetal growth.
- Cesarean Section: Due to the complexity of the procedure and the risk of complications, all births are by scheduled cesarean section.
Positive Results in Texas
The uterus transplant program at Baylor University Medical Center has achieved very promising results. To date, numerous healthy births have been reported, with the overall success rate continuing to improve due to continued optimization of surgical techniques and postoperative management. According to published data, approximately 75% of transplants performed in Texas have resulted in a successful pregnancy, with a live birth rate of 90% among initiated pregnancies. Postoperative surveys have shown a high level of satisfaction among recipients, not only with the ability to carry a pregnancy to term, but also with the improvement in quality of life and psychological well-being.
Challenges and ethical considerations
Despite promising results, uterus transplantation poses a number of ethical and practical challenges that must be carefully considered. Living donor transplantation raises ethical concerns regarding risks to the donor, including those related to surgery and the potential compromise of future health. Furthermore, uterus transplantation is an extremely expensive and complex procedure, accessible only to a minority of patients. The issue of accessibility and distributive justice is central to the debate on the diffusion of this technology. Finally, recipients must deal not only with the physical challenges of transplantation and pregnancy, but also with the psychological complexities associated with motherhood after transplantation. The need for long-term psychological support is essential.
Future prospects
Future technological innovations could make uterus transplantation safer, more effective and accessible. The development of less invasive surgical techniques could reduce trauma for donors and recipients, improving recovery times and reducing associated risks. Research on xenotransplantation, or transplantation of organs from different species (for example, genetically modified pigs), could offer new solutions to overcome the shortage of human donors. Finally, tissue engineering and the use of artificial wombs could, in the not too distant future, offer an alternative solution to uterus transplantation, reducing risks and expanding treatment options.
- Edited by Dr. Gianfrancesco Cormaci, PhD, specialist in Clinical Biochemistry.
Scientific references
Brännström M, Belfort M et al. (2021). Transplantation, 105(4), 677.
Tzakis AG et al. (2020). Journal of Clinical Medicine, 9(8), 2408.
Testa G et al. (2017). Amer J Transplantation, 17(10), 2763-2768.
Flyckt R et al. (2017). Curr Opin Organ Transplant, 22(6), 593-599.
Flyckt RL et al. (2016). Amer J Obstet Gynecol. 215(4), 417.e1-e7.
Brännström M et al. (2015). The Lancet, 385(9968), 607-616.
Johannesson L et al. (2014). Fertility Sterility, 101(5), 1228-1236.